Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 14
1987 73
1988 78
1989 85
1990 131
1991 163
1992 213
1993 289
1994 337
1995 404
1996 338
1997 311
1998 370
1999 437
2000 386
2001 349
2002 341
2003 304
2004 299
2005 326
2006 377
2007 352
2008 331
2009 370
2010 403
2011 377
2012 369
2013 336
2014 324
2015 297
2016 270
2017 240
2018 182
2019 73
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

8,978 results
Results by year
Filters applied: . Clear all
Page 1
Design and construction of a new recombinant fusion protein (2b2t+EPC1) and its assessment for serodiagnosis of cystic echinococcosis.
Fathi S, et al. APMIS 2018. PMID 29696723
The specificity of the recombinant fusion protein (95.45%) was not significantly lower than the commercial kit (96.59%; p = 1.000). ...In conclusion, as an early evaluation of these antigens the performance of our recombinant fusion protein in ELISA is relatively promising. ...
The specificity of the recombinant fusion protein (95.45%) was not significantly lower than the commercial kit (96.59%; p = 1.000). . …
Antibody fusion proteins with human ribonucleases 1 to 8
Wezler X, et al. Hum Antibodies 2018. PMID 29689715
ImmunoRNase fusion proteins were constructed using the CD30-specific bivalent recombinant scFv-Fc antibody SH313-B5. Production of the resulting entirely human immunoRNases 1 to 8 was done in mammalian cells by secretion of active forms. ...
ImmunoRNase fusion proteins were constructed using the CD30-specific bivalent recombinant scFv-Fc antibody SH313-B5. Production of th …
8,978 results
Jump to page
Feedback